Condition
Homozygous Familial Hypercholesterolemia (HoFH) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Homozygous Familial Hypercholesterolemia (HoFH) clinical trials that are recruiting, at sites in 9 countries (most in United States (2), Australia (1), New Zealand (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest Homozygous Familial Hypercholesterolemia (HoFH) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CTX310 for refractory high triglycerides or LDL cholesterol | Phase 1 | Hialeah, Florida and 16 other locations | Recruiting | Mar 24, 2026 |
| EDP167 dose testing for homozygous familial hypercholesterolemia | Phase 2 | Beijing | Recruiting | Mar 24, 2026 |
| ORIGIN-FH: Newborn screening to detect familial high cholesterol | — | Madison, Wisconsin | Recruiting | Mar 13, 2026 |
| Intensifying lipid-lowering with evinacumab to reduce coronary plaque in homozygous familial hypercholesterolemia | — | Paris and 12 other locations | Recruiting | Mar 3, 2026 |
All recruiting trials (4)
-
CTX310 for refractory high triglycerides or LDL cholesterol
This trial will test whether a single IV dose of CTX310 is safe and tolerated in adults whose high triglycerides or LDL cholesterol have not responded to available treatments.
-
EDP167 dose testing for homozygous familial hypercholesterolemia
This trial tests whether two injections of an siRNA drug called EDP167 can lower ANGPTL3 and improve lipid levels in adults with homozygous familial hypercholesterolemia (HoFH).
-
ORIGIN-FH: Newborn screening to detect familial high cholesterol
This project will test a genetic cheek swab of parents plus blood screening of newborns to find familial high cholesterol in babies born to parents with familial hypercholesterolemia.
-
Intensifying lipid-lowering with evinacumab to reduce coronary plaque in homozygous familial hypercholesterolemia
This project will test whether adding evinacumab to existing lipid-lowering therapy can shrink or slow coronary plaque buildup in people with homozygous familial hypercholesterolemia using CCTA imaging.
Related topics
Quick answers
How many Homozygous Familial Hypercholesterolemia (HoFH) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (2 trials), Australia (1 trial), New Zealand (1 trial), United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.